메뉴 건너뛰기




Volumn 11, Issue 1, 2004, Pages 92-99

Neurotoxicity of taxanes: Symptoms and quality of life assessment

Author keywords

Breast cancer; Neurotoxicity; Quality of life; Taxane

Indexed keywords

ANTINEOPLASTIC AGENT; TAXOID;

EID: 1542379860     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02968010     Document Type: Review
Times cited : (81)

References (52)
  • 6
    • 0033915199 scopus 로고    scopus 로고
    • Managing the neurotoxicity of paclitaxel (Taxol®) and docetaxel (Taxotere®) with neurotrophic factors
    • Apfel SC: Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors. Cancer Invest 18:564-573, 2000. (Pubitemid 30485673)
    • (2000) Cancer Investigation , vol.18 , Issue.6 , pp. 564-573
    • Apfel, S.C.1
  • 8
    • 0033921499 scopus 로고    scopus 로고
    • Phantom limb pain as a manifestation of paclitaxel neurotoxicity
    • Khattab J, Terebelo HR, Dabas B: Phantom limb pain as a manifestation of paclitaxel neurotoxicity. Mayo Clin Proc 75:740-742, 2000. (Pubitemid 30441504)
    • (2000) Mayo Clinic Proceedings , vol.75 , Issue.7 , pp. 740-742
    • Khattab, J.1    Terebelo, H.R.2    Daras, B.3
  • 12
    • 0035890811 scopus 로고    scopus 로고
    • Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer
    • Perez EA, Vogel CL, Irwin DH, Kirshner JJ, Patel R: Multicenter phase II trial of weekly paclitaxel in women with metastatic breast cancer. J Clin Oncol 19:4216-4223, 2001. (Pubitemid 33081639)
    • (2001) Journal of Clinical Oncology , vol.19 , Issue.22 , pp. 4216-4223
    • Perez, E.A.1    Vogel, C.L.2    Irwin, D.H.3    Kirshner, J.J.4    Patel, R.5
  • 13
    • 0037231194 scopus 로고    scopus 로고
    • Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer
    • Christodoulou C, Klouvas G, Pateli A, Mellou S, Sgouros J, Skarlos DV: Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer. Anticancer Res 23:737-744, 2003. (Pubitemid 36358482)
    • (2003) Anticancer Research , vol.23 , Issue.B1 , pp. 737-744
    • Christodoulou, C.1    Klouvas, G.2    Pateli, A.3    Mellou, S.4    Sgouros, J.5    Skarlos, D.V.6
  • 14
    • 0037977159 scopus 로고    scopus 로고
    • Weekly paclitaxel (Taxol®) with or without trastuzumab (Herceptin®) in advanced breast cancer: A community-based observation study
    • DOI 10.1159/000069832
    • von Moos R, Thurlimann B: Weekly Paclitaxel (Taxol(R)) with or without Trastuzumab (Herceptin (R)) in Advanced Breast Cancer: A Community- Based Observation Study. Onkologie 26:128-132, 2003. (Pubitemid 36677076)
    • (2003) Onkologie , vol.26 , Issue.2 , pp. 128-132
    • Von Moos, R.1    Thurlimann, B.2
  • 16
    • 0346455296 scopus 로고    scopus 로고
    • Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer
    • Kuroi K, Tanaka C, Bando H, Saji S, Hayashi K, Toi M" Efficacy of biweekly paclitaxel therapy in advanced or recurrent breast cancer. Gan To Kagaku Ryoho 29:55-60, 2002.
    • (2002) Gan to Kagaku Ryoho , vol.29 , pp. 55-60
    • Kuroi, K.1    Tanaka, C.2    Bando, H.3    Saji, S.4    Hayashi, K.5    Toi, M.6
  • 23
    • 0028270476 scopus 로고
    • Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies
    • Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR: Peripheral neuropathy from taxol and cisplafin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol 35:304-311, 1994. (Pubitemid 24089653)
    • (1994) Annals of Neurology , vol.35 , Issue.3 , pp. 304-311
    • Chaudhry, V.1    Rowinsky, E.K.2    Sartorius, S.E.3    Donehower, R.C.4    Cornblath, D.R.5
  • 25
    • 0028943926 scopus 로고
    • Neurotoxicity of cisplatin and taxol
    • Warner E: Neurotoxicity of cisplatin and taxol. Int J Gynecol Cancer 5:161-169, 1995.
    • (1995) Int J Gynecol Cancer , vol.5 , pp. 161-169
    • Warner, E.1
  • 27
    • 0038206660 scopus 로고    scopus 로고
    • Managing taxane toxicities
    • Markman M: Managing taxane toxicities. Support Care Cancer 11:144-147, 2003. (Pubitemid 36733807)
    • (2003) Supportive Care in Cancer , vol.11 , Issue.3 , pp. 144-147
    • Markman, M.1
  • 30
    • 0029948062 scopus 로고    scopus 로고
    • Transient encephalopathy after paclitaxel (Taxol) infusion
    • Perry JR, Warner E: Transient encephalopathy after paclitaxel (Taxol) infusion. Neurology 46:1596-1599, 1996. (Pubitemid 26185778)
    • (1996) Neurology , vol.46 , Issue.6 , pp. 1596-1599
    • Perry, J.R.1    Warner, E.2
  • 34
    • 0029889373 scopus 로고    scopus 로고
    • Peripheral neuropathy secondary to docetaxel (Taxotere)
    • New PZ, Jackson CE, Rinaldi D, Burris H, Barohn RJ: Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology 46:108-111, 1996. (Pubitemid 26156112)
    • (1996) Neurology , vol.46 , Issue.1 , pp. 108-111
    • New, P.Z.1    Jackson, C.E.2    Rinaldi, D.3    Burris, H.4    Barohn, R.J.5
  • 39
    • 0036302586 scopus 로고    scopus 로고
    • Phase II study of weekly docetaxel in patients with metastatic breast cancer
    • DOI 10.1093/annonc/mdf027
    • Aihara T, Kim Y, Takatsuka Y: Phase I study of weekly docetaxel in patients with metastatic breast cancer. Ann Oncol 13:286-292, 2002. (Pubitemid 34704982)
    • (2002) Annals of Oncology , vol.13 , Issue.2 , pp. 286-292
    • Aihara, T.1    Kim, Y.2    Takatsuka, Y.3
  • 40
    • 2142856685 scopus 로고    scopus 로고
    • Protracted administration of weekly docetaxel in metastatic breast cancer
    • Kuroi K, Bando H, Saji S, Toi M: Protracted administration of weekly docetaxel in metastatic breast cancer. Oneol Rep 10:1479-1484, 2003.
    • (2003) Oneol Rep , vol.10 , pp. 1479-1484
    • Kuroi, K.1    Bando, H.2    Saji, S.3    Toi, M.4
  • 41
    • 0031752909 scopus 로고    scopus 로고
    • Docetaxel and cisplatin in metastatic urothelial cancer: A phase II study
    • Sengelov L, Kamby C, Lund B, Engelholm SA: Docetaxel and cisplatin in metastatic urothelial cancer: a phase II study. J Clin Oncol 16:3392-3397, 1998. (Pubitemid 28481638)
    • (1998) Journal of Clinical Oncology , vol.16 , Issue.10 , pp. 3392-3397
    • Sengelov, L.1    Kamby, C.2    Lund, B.3    Engelholm, S.A.4
  • 42
    • 0031058721 scopus 로고    scopus 로고
    • Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere)
    • DOI 10.1023/A:1008245400251
    • Hilkens PH, Verweij J, Vecht CJ, Stoter G, van den Bent MJ: Clinical characteristics of severe peripheral neuropathy induced by docetaxel (Taxotere). Ann Oncol 8:187-190, 1997. (Pubitemid 27112888)
    • (1997) Annals of Oncology , vol.8 , Issue.2 , pp. 187-190
    • Hilkens, P.H.E.1    Verweij, J.2    Vecht, Ch.J.3    Stoter, G.4    Van Den Bent, M.J.5
  • 43
    • 0036360434 scopus 로고    scopus 로고
    • Quality of life assessment
    • Shimozuma K: Quality of life assessment. Breast Cancer 9:100-106, 2002.
    • (2002) Breast Cancer , vol.9 , pp. 100-106
    • Shimozuma, K.1
  • 44
    • 0036369954 scopus 로고    scopus 로고
    • Hisashige for the task force of the japanese breast cancer society for 'the development of guidelines for quality of life assessment studies of breast cancer patients a: Systematic overview of quality of life studies for breast cancer
    • Shimozuma K, Okamoto T, Katsumata N, Koike M, Tanaka K, Osumi S, Saito M, Shikama N, Watanabe T, Mitsumori M, Yamauchi C, Hisashige for The Task Force of The Japanese Breast Cancer Society for 'The Development of Guidelines for Quality of Life Assessment Studies of Breast Cancer Patients A: Systematic Overview of Quality of Life Studies for Breast Cancer. Breast Cancer 9:196-202, 2002.
    • (2002) Breast Cancer , vol.9 , pp. 196-202
    • Shimozuma, K.1    Okamoto, T.2    Katsumata, N.3    Koike, M.4    Tanaka, K.5    Osumi, S.6    Saito, M.7    Shikama, N.8    Watanabe, T.9    Mitsumori, M.10    Yamauchi, C.11
  • 45
    • 84858118341 scopus 로고    scopus 로고
    • Breast cancer treatment and quality of life of patients
    • Ohsumi S, Shimozuma K: Breast cancer treatment and quality of life of patients. Jpn J Breast Cancer 18:113-120, 2003.
    • (2003) Jpn J Breast Cancer , vol.18 , pp. 113-120
    • Ohsumi, S.1    Shimozuma, K.2
  • 50
    • 0036727187 scopus 로고    scopus 로고
    • Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer
    • DOI 10.1200/JCO.2002.08.057
    • Modi S, Panageas KS, Duck ET, Bach A, Weinstock N, Dougherty J, Cramer L, Hudis C, Norton L, Seidman A: Prospective exploratory analysis of the association between tumor response, quality of life, and expenditures among patients receiving paclitaxel monotherapy for refractory metastatic breast cancer. J Clin Onco120:3665-3673, 2002. (Pubitemid 34983227)
    • (2002) Journal of Clinical Oncology , vol.20 , Issue.17 , pp. 3665-3673
    • Modi, S.1    Panageas, K.S.2    Duck, E.T.3    Bach, A.4    Weinstock, N.5    Dougherty, J.6    Cramer, L.7    Hudis, C.8    Norton, L.9    Seidman, A.10
  • 52
    • 0033860004 scopus 로고    scopus 로고
    • Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: Quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam Symptom Checklist
    • DOI 10.1016/S0959-8049(00)00134-9, PII S0959804900001349
    • Kramer JA, Curran D, Piccart M, de Haes JC, Bruning PF, Klijn JG, Bontenbal M, van Pottelsberghe C, Groenvold M, Paridaens R: Randomised trial of paclitaxel versus doxorubicin as first-line chemotherapy for advanced breast cancer: quality of life evaluation using the EORTC QLQ-C30 and the Rotterdam symptom checklist. EurJ Cancer 36:1488-1497, 2000. (Pubitemid 30619001)
    • (2000) European Journal of Cancer , vol.36 , Issue.12 , pp. 1488-1497
    • Kramer, J.A.1    Curran, D.2    Piccart, M.3    De Haes, J.C.J.M.4    Bruning, P.F.5    Klijn, J.G.M.6    Bontenbal, M.7    Van Pottelsberghe, C.8    Groenvold, M.9    Paridaens, R.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.